PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Cinnamon enhanced glucose transport and enzyme inhibition; human studies showed reductions in fasting blood glucose (12.9 to 52.2 mg/dL) and HbA1c (0.27 to 0.83%) [PMID:40641727, PMID:30144878]
A phase II trial of CKD-495 (extracted from C. cassia) showed a significantly higher endoscopic erosion improvement rate (73%) compared to other groups (41-52%) [PMID:40255536]
Cinnamomum cassia was identified as having high xanthine oxidase inhibitory activity (>85%) [PMID:29628890]
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 39736250 (2025) — Bioinformatics identification based on causal association inference using multi-omics reveals the underlying mechanism of Gui-Zhi-Shao-Yao-Zhi-Mu decoction in modulating rheumatoid arthritis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 29145172 (2018) — Volatiles from Cinnamomum cassia buds. · Zeitschrift fur Naturforschung. C, Journal of biosciences
- 3.PMID: 29628890 (2018) — Anti-gout Potential of Malaysian Medicinal Plants. · Frontiers in pharmacology
- 4.PMID: 35004802 (2021) — A Review on the Mechanism and Application of Keishibukuryogan. · Frontiers in nutrition
- 5.PMID: 28866770 (2017) — Anti-coagulant activity of plants: mini review.